基于团队与基于技术的支持性癌症护理:多站点实施的混合方法研究
Sacha Moufarrej1, Emily H Wood2, Niharika Dixit3
11University of California San Diego School of Medicine, San Diego, CA.
Journal of the National Comprehensive Cancer Network : JNCCN
|November 10, 2025
概括
支持性癌症护理 (SCC) 是至关重要的,但面临实施障碍. 基于团队的SCC看起来很有前途,但基于技术的方法可能会加剧差距,而不解决基础设施和政策挑战.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 实施科学 实施科学
背景情况:
- 支持性癌症护理 (SCC),包括事先的护理计划和症状管理,是癌症患者的国家建议.
- 持续存在的障碍阻碍了SCC的有效实施,需要创新的实施策略.
- 启动了一项多站点临床试验,以比较由非专业卫生教育工作者领导的团队式SCC与基于技术的SCC教育交付.
研究的目的:
- 确定不同SCC交付模式的实施障碍和促进者.
- 评估基于团队与基于技术的SCC方法的比较有效性,实施,采用和可持续性.
- 了解SCC对潜在付款人退款的护理总成本的影响.
主要方法:
- 采用了融合的并行混合方法方法,将半结构面试和调查与26家癌症诊所的研究人员相结合.
- 采访中的定性数据使用内容分析进行分析,而调查数据使用描述性统计数据进行分析.
- 实施研究综合框架 (CFIR) 和RE-AIM框架指导研究设计和分析.
主要成果:
- 参与者普遍认识到SCC对癌症患者的基本性质.
- 确定了基础设施和文化障碍,包括资金,优先级,耻辱和患者需求的多样性.
- 虽然以团队为基础的SCC得到了广泛的支持,但人们担心仅仅基于技术的方法可能会加剧癌症差异.
结论:
- 重要的基础设施,组织和政策因素极大地影响了SCC在临床实践中的适应性和可持续性.
- 这些因素可能会影响正在进行的试验中评估的SCC方法的比较有效性.
- 解决已确定的障碍对于成功实施和支持性癌症护理服务的长期可持续性至关重要.
相关概念视频
01:21Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:20Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:15Methods of Documentation VI: Case Management Model
844
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
844
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K